Overview

Aneurysm Treatment Market Introduction Aneurysm Treatment Market foreseen to grow over a CAGR of 5% during 2020-2027. Brain aneurysm, which is observed at the base of the brain, is a balloon-like or bulging growth. It typically appears in areas where larger arteries are branched into smaller ones. It is also known as intracranial aneurysm or cerebral aneurysm. Aneurysm results into stroke or brain damage due to the rupturing which results into bleeding in the sub-arachnoid area which may sometimes even lead to death. Until the swelling ruptures, brain aneurysm rarely shows any symptoms. However, localized headache, cranial nerve palsy and double vision of brain aneurysm that has a mass effect on the neurological structures adjacent to it. Some of the key causes of brain aneurysm are aging, heredity, brain injury and atherosclerosis. It is generally treated with surgical clipping, flow diverters, and endovascular coiling. An aneurysm is associated with fatality and has a high risk of potential complications. Rising prevalence of aneurysm is expected to fuel the growth of the market. According to the CDC, annually aneurysm contributes to more than 25,000 deaths in the U.S. and an estimated 40% of these cases can cause death in less than one day. As it is a fatal complication, an aneurysm requires immediate medical attention and has a huge demand in primary healthcare settings. Along with this, healthcare systems are more focused on preventive techniques to control the incidence. All these factors led to the potential growth of the market during the forecast period. Further, increasing awareness and increasing healthcare expenditure fuelled the growth of the market. Developed economies like North America and Europe is expected to witness a high market share in the global market due to high awareness among the general population. Established healthcare systems and reimbursement policies in these regions are expected to drive the growth of the market. Asia-Pacific region is expected to witness a high market growth rate during the forecast period due to high prevalence. Asia Pacific region is dominated by local manufacturers and expected to remain the same throughout the forecast period. Latin America is the second fast-growing region in the global market due to increasing awareness. Rest of world accounts the small fraction of market share in the global market Aneurysm Treatment market players include: Penumbra, Terumo Medical Incorporated, Medtronic Plc, Phenox GmbH B. Braun Melsungen AG, Stryker, and Raumedic AG, DePuy Synthes, Integra Life Sciences Corporation, Orsan Medical Technologies, Spiegelberg GmbH, MicroPort Scientific Corporation, Codman & Shurtleff, Inc. Aneurysm Treatment Market Segmentation By Product Type Surgical Clipping

Endovascular Coiling

Flow diverters By End User Hospitals

Neurological Centres By Region North America

Latin America

Europe

Asia Pacific

Rest of the World Competitive Landscape • Tier 1 players- established companies in the market with a major market share

• Tier 2 players

• Emerging players which are growing rapidly

• New Entrants FutureWise Key Takeaways • Growth prospects

• SWOT analysis

• Key trends

• Key data-points affecting market growth Objectives of the Study:

• To provide with an exhaustive analysis on the global Aneurysm Treatment Market by Product Type, by End User, and by Region

• To cater comprehensive information on factors impacting market growth (drivers, restraints, opportunities, and industry-specific restraints)

• To evaluate and forecast micro-markets and the overall market

• To predict the market size, in key regions (along with countries)—North America, Europe, Asia Pacific, Latin America, and the Middle East

• To record evaluate and competitive landscape mapping- product launches, technological advancements, mergers and expansions

• Profiling of companies to evaluate their market shares, strategies, financials and core competencies.